Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Chiou, Chien-Shun
Liao, Jui-Cheng
Liao, Tsai-Ling
Li, Chun-Chin
Chou, Chen-Ying
Chang, Hsiu-Li
Yao, Shu-Man
and
Lee, Yeong-Sheng
2006.
Molecular epidemiology and emergence of worldwide epidemic clones of Neisseria meningitidis in Taiwan.
BMC Infectious Diseases,
Vol. 6,
Issue. 1,
Wang, Cheng-Yi
Chuang, Yu-Min
Teng, Lee-Jene
Lee, Li-Na
Yang, Pan-Chyr
Kuo, Sow-Hsong
and
Hsueh, Po-Ren
2006.
Bacteraemic pneumonia caused by Neisseria lactamica with reduced susceptibility to penicillin and ciprofloxacin in an adult with liver cirrhosis.
Journal of Medical Microbiology
,
Vol. 55,
Issue. 8,
p.
1151.
Wang, Jiun-Ling
Liu, Ding-Ping
Yen, Jer-Jea
Yu, Chia-Jung
Liu, Hsi-Chen
Lin, Ching-Yuang
and
Chang, Shan-Chwen
2006.
Clinical features and outcome of sporadic serogroup W135 disease Taiwan.
BMC Infectious Diseases,
Vol. 6,
Issue. 1,
Yang, Chiou-Ying
Lee, Yeong-Sheng
Huang, Lan-Shiang
Kuo, Yen-Liang
Liu, Yi-Lun
and
Lu, Cheng-Hsiung
2006.
Antigenic diversity ofNeisseria meningitidisisolated in Taiwan between 1995 and 2002.
Scandinavian Journal of Infectious Diseases,
Vol. 38,
Issue. 4,
p.
273.
Gatchalian, S.
Palestroque, E.
De Vleeschauwer, I.
Han, H.H.
Poolman, J.
Schuerman, L.
Dobbelaere, K.
and
Boutriau, D.
2008.
The development of a new heptavalent diphtheria–tetanus–whole cell pertussis–hepatitis B–Haemophilus influenzae type b–Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
International Journal of Infectious Diseases,
Vol. 12,
Issue. 3,
p.
278.
Bash, Margaret C.
McKnew, Durrie L.
and
Tapsall, John W.
2009.
Antimicrobial Drug Resistance.
p.
763.
VYSE, A.
WOLTER, J. M.
CHEN, J.
NG, T.
and
SORIANO-GABARRO, M.
2011.
Meningococcal disease in Asia: an under-recognized public health burden.
Epidemiology and Infection,
Vol. 139,
Issue. 7,
p.
967.
da Silva, Luiz Jacintho
DeTora, Lisa
Malerczyk, Claudius
and
Memish, Ziad A
2012.
Emergence ofNeisseria meningitidisW-135 in the context of other rare serogroups.
Clinical Investigation,
Vol. 2,
Issue. 2,
p.
177.
Vesikari, Timo
Forstén, Aino
Boutriau, Dominique
Bianco, Véronique
Van der Wielen, Marie
and
Miller, Jacqueline M.
2012.
Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers.
Human Vaccines & Immunotherapeutics,
Vol. 8,
Issue. 12,
p.
1892.
Ruiz-Palacios, Guillermo M.
Huang, Li-Min
Lin, Tzou-Yien
Hernandez, Lorena
Guerrero, M. Lourdes
Villalobos, Antonio Lavalle
Van der Wielen, Marie
Moreira, Marta
Fissette, Laurence
Borys, Dorota
and
Miller, Jacqueline M.
2013.
Immunogenicity and Safety of a Booster Dose of the 10-valent Pneumococcal Haemophilus Influenzae Protein D Conjugate Vaccine Coadministered With the Tetravalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine in Toddlers.
Pediatric Infectious Disease Journal,
Vol. 32,
Issue. 1,
p.
62.
Huang, Li-Min
Chiu, Nan-Chang
Yeh, Shu-Jen
Bhusal, Chiranjiwi
and
Arora, Ashwani Kumar
2014.
Immunogenicity and safety of a single dose of a CRM-conjugated meningococcal ACWY vaccine in children and adolescents aged 2–18 years in Taiwan: Results of an open label study.
Vaccine,
Vol. 32,
Issue. 40,
p.
5177.
Lien, Chia-Yi
Lee, Jun-Jun
Tsai, Wan-Chen
Chen, Shih-Ying
Huang, Chi-Ren
Chien, Chun-Chih
Lu, Cheng-Hsien
and
Chang, Wen-Neng
2019.
The clinical characteristics of spontaneous Gram-negative bacterial meningitis in adults: A hospital-based study.
Journal of Clinical Neuroscience,
Vol. 64,
Issue. ,
p.
101.
Chiou, Chien-Shun
Liao, Ying-Shu
Chen, Bo-Han
Lu, Min-Chi
Hong, Yu-Ping
Wang, You-Wun
Teng, Ru-Hsiou
and
Andam, Cheryl P.
2022.
Demographic Features of Invasive Meningococcal Disease in Taiwan, 1993 to 2020, and Genetic Characteristics of Neisseria meningitidis Isolates, 2003 to 2020.
Microbiology Spectrum,
Vol. 10,
Issue. 4,